Clinical Trials Browser

Phase 1/2 × NETWORK × Cyclophosphamide × Clear all

NCT01857115 2024-11-13

wCCyd

Phase 1/2 Completed

Disease, Multiple Myeloma

NCT02204241 2023-07-03

CCD

Phase 1/2 Completed

Disease, Multiple Myeloma

NCT00098839 2017-12-12

Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL)

Phase 1/2 Completed

134 enrolled 13 charts

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma